From 1.5 g ALCAR twice daily (23 patients, plasma levels from 15 patients obtained), the treatment was changed to once daily doses of 1g (4 patients), 2g (7 patients), or 3g (12 patients), respectively
P = 0.001), suggesting a potential gender-related difference in treatment response
When scaled by the number of years each person was in the trial, there were 5.8 events for every 100 years of follow-up among those taking semaglutide, compared with 7.5 events for every 100 years of follow-up among those who received the placebo
it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease
Managing and Preventing Leg Cramps on Wegovy If you experience leg cramps whilst taking Wegovy, several practical strategies may help manage and prevent them